Osiris Therapeutics, Inc. News
Osiris Therapeutics (OSIR) Weak On High Volume Today
Trade-Ideas LLC identified Osiris Therapeutics (OSIR) as a weak on high relative volume candidate
'Mad Money' Lightning Round: I'm Not Abandoning Rite Aid
Cramer says Osiris Therapeutics is exciting, Opko Health is a buy and you can't go wrong with PPG Industries.
Jim Cramer's 'Mad Money' Recap: Be Patient, Then Start Buying
Markets weren't as overheated today, Cramer says. You can buy stocks at great prices if you are patient.
Elon Musk and Tesla Set Their Sights on a Popular Industry
The electric vehicle manufacturer has a very popular industry in its sights despite often low margins.
Luxury-Home Builder Toll Brothers Beats Q2 Profit, Revenue Estimates
Toll Brothers earned $1.85 a share in its fiscal second quarter on 18% higher revenue.